Newbridge Financial Services Group, Inc. Biomarin Pharmaceutical Inc Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$71.48 - $86.85 $1,143 - $1,389	-16 Reduced 29.63%	38 $3,000
Q4 2021 Jan 19, 2022	SELL	$71.72 - $91.47 $34,712 - $44,271	-484 Reduced 89.96%	54 $5,000
Q2 2021 Sep 07, 2021	BUY	$75.51 - $84.79 $37,755 - $42,395	500 Added 1315.79%	538 $45,000
Q1 2021 Sep 07, 2021	BUY	$74.73 - $90.69 $2,839 - $3,446	38 New	38 $3,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.